"10.1371_journal.pone.0089612","plos one","2014-02-26T00:00:00Z","Andre S Nell; Eva D’lom; Patrick Bouic; Montserrat Sabaté; Ramon Bosser; Jordi Picas; Mercè Amat; Gavin Churchyard; Pere-Joan Cardona","PAREXEL Early Phase Clinical Unit, Bloemfontein, South Africa; PAREXEL International, Madrid, Spain; Synexa Life Sciences, Cape Town, South Africa; TFS Develop, Barcelona, Catalonia, Spain; Janus Developments, Barcelona, Catalonia, Spain; Archivel Farma, Badalona, Catalonia, Spain; The Aurum Institute, Johannesburg, South Africa; Unitat de Tuberculosi Experimental (UTE), Institut per a la Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain","Conceived and designed the experiments: ASN EDI PB RB JP MA GC PJC. Performed the experiments: ASN EDI PB. Analyzed the data: ASN PB RB JP MA GC PJC. Contributed reagents/materials/analysis tools: ASN EDI PB MS. Wrote the paper: MS RB JP MA GC PJC.","The following statement was included in the cover letter: Jordi Picas and Mercè Amat are employees of Archivel Farma S.L., Pere-Joan Cardona is consultant of Archivel Farma S.L., Andre S. Nell and Eva Dlom are employees of PAREXEL (South Africa) and PAREXEL International (Spain), respectively. Patrick Bouic is employee of Synexa Life Sciences (SouthAfrica), Ramon Bosser is employee of Janus Developments (Spain), and Montserrat Sabaté is an employee of TFS Develop (Spain). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Pere Joan Cardona is editor of PLOS ONE. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Andre S Nell","ASN",9,TRUE,8,3,7,6,TRUE,TRUE,TRUE,1,"2",FALSE
